Sugi Predict

Sugi Predict / Compounds / SCHEMBL199218

SCHEMBL199218

SCHEMBL199218

[CH2]CCCCC(C)CCCCC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACE2 Q9BYF1 1/20 0.48
▸ OPRM1 P35372 1/20 0.46
▸ LMNA P02545 2/20 0.43
▸ CA1 P00915 2/20 0.38
▸ SPHK1 Q9NYA1 1/20 0.38
▸ PRKD3 O94806 1/20 0.38
▸ PRKCG P05129 1/20 0.38
▸ PRKCB P05771 1/20 0.38
▸ PRKCA P17252 1/20 0.38
▸ PRKCH P24723 1/20 0.38
▸ PRKCI P41743 1/20 0.38
▸ PRKCE Q02156 1/20 0.38
▸ PRKCQ Q04759 1/20 0.38
▸ PRKCZ Q05513 1/20 0.38
▸ PRKCD Q05655 1/20 0.38
▸ PRKD1 Q15139 1/20 0.38
▸ TP53 P04637 1/20 0.37
▸ DNM1 Q05193 2/20 0.36
▸ ADH1B P00325 1/20 0.35
▸ ADH1C P00326 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8843869 0.97 ACE2 (0.52) ACE2OPRM1LMNASPHK1PRKD3
SCHEMBL3949790 0.97 ACE2 (0.52) ACE2OPRM1LMNASPHK1PRKD3
SCHEMBL3366483 0.97 ACE2 (0.52) ACE2OPRM1LMNASPHK1PRKD3
SCHEMBL25185981 0.97 ACE2 (0.52) ACE2OPRM1LMNASPHK1PRKD3
SCHEMBL25178063 0.97 ACE2 (0.52) ACE2OPRM1LMNASPHK1PRKD3
SCHEMBL25185241 0.97 ACE2 (0.52) ACE2OPRM1LMNASPHK1PRKD3
SCHEMBL25186110 0.97 ACE2 (0.52) ACE2OPRM1LMNASPHK1PRKD3
SCHEMBL25181811 0.97 ACE2 (0.52) ACE2OPRM1LMNASPHK1PRKD3
SCHEMBL21219900 0.97 ACE2 (0.52) ACE2OPRM1LMNASPHK1PRKD3
SCHEMBL1812974 0.97 ACE2 (0.52) ACE2OPRM1LMNASPHK1PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024147345-A1 COATED NEGATIVE ELECTRODE ACTIVE MATERIAL PARTICLES FOR LITHIUM ION BATTERIES, NEGATIVE ELECTRODE FOR LITHIUM ION BATTERIES, LITHIUM ION BATTERY, AND METHOD FOR PRODUCING COATED NEGATIVE ELECTRODE ACTIVE MATERIAL PARTICLES FOR LITHIUM ION BATTERIES ＡＰＢ株式会社 2024-07-11 — — WO disclosed
CN-118201905-A Cationic lipid 武田药品工业株式会社 2024-06-14 — — CN disclosed
WO-2024018761-A1 NEUTRAL LIPID AND LIPID NANOPARTICLE 国立大学法人北海道大学 2024-01-25 — — WO disclosed
US-20240024252-A1 LIPID NANOPARTICLE NITTO DENKO CORPORATION (JP) 2024-01-25 — — US disclosed
WO-2024018762-A1 PH-SENSITIVE CATIONIC LIPID AND LIPID NANOPARTICLE 国立大学法人北海道大学 2024-01-25 — — WO disclosed
CN-117062872-A Polymer composition comprising a polyacrylic block copolymer and an aromatic polyoxyalkylene as dispersant 巴斯夫欧洲公司 2023-11-14 — — CN disclosed
WO-2023204215-A1 ELECTRODE COMPOSITION FOR LITHIUM ION BATTERIES, COATED NEGATIVE ELECTRODE ACTIVE MATERIAL PARTICLES FOR LITHIUM ION BATTERIES, METHOD FOR PRODUCING COATED NEGATIVE ELECTRODE ACTIVE MATERIAL PARTICLES FOR LITHIUM ION BATTERIES, NEGATIVE ELECTRODE FOR LITHIUM ION BATTERIES, AND LITHIUM ION BATTERY ＡＰＢ株式会社 2023-10-26 — — WO disclosed
US-20230317953-A1 COATED NEGATIVE ELECTRODE ACTIVE MATERIAL PARTICLES FOR LITHIUM ION BATTERIES, NEGATIVE ELECTRODE FOR LITHIUM ION BATTERIES, LITHIUM ION BATTERY, AND METHOD FOR PRODUCING COATED NEGATIVE ELECTRODE ACTIVE MATERIAL PARTICLES FOR LITHIUM ION BATTERIES APB CORPORATION (JP) 2023-10-05 — — US disclosed
WO-2023191050-A1 PHARMACEUTICAL COMPOSITION FOR DELIVERY TO CANCER, OR IMMUNOSTIMULATING COMPOSITION 日東電工株式会社 2023-10-05 — — WO disclosed
WO-2023188830-A1 LIPID NANOPARTICLES 国立大学法人北海道大学 2023-10-05 — — WO disclosed
WO-1993008161-A1 SULFONYL UREA AND CARBAMATE ACAT INHIBITORS WARNER-LAMBERT COMPANY (US) 1993-04-29 — — WO disclosed
US-4140516-A Encapsulation process employing phase transfer catalysts STAUFFER CHEMICAL COMPANY (US) 1979-02-20 — — US disclosed
US-4134985-A 5-CYCLOPROPANE CARBOXYLATE OXADIAZOLES AS INSECTICIDES AND ACARICIDES STAUFFER CHEMICAL COMPANY (US) 1979-01-16 — — US disclosed
US-4093622-A Pyridine esters of cyclopropane-carboxylic acid ZOECON CORPORATION (US) 1978-06-06 — — US disclosed
US-4014922-A CYCLOPROPYL SUBSTITUTED ESTERS; MITICIDES ZOECON CORPORATION (US) 1977-03-29 — — US disclosed
US-4008258-A MITICIDE ZOECON CORPORATION (US) 1977-02-15 — — US disclosed
US-3995054-A MITICIDES ZOECON CORPORATION (US) 1976-11-30 — — US disclosed
US-3975429-A Cyclopropanemethyl esters of cinnamic acid and derivatives thereof ZOECON CORPORATION (US) 1976-08-17 — — US disclosed
US-3969384-A Esters of cyclopropane alkanoic acids ZOECON CORPORATION (US) 1976-07-13 — — US disclosed
US-3948961-A CYCLOPROPYL ALKYL CARBOXYLATES, MITICIDE, INSECTICIDE ZOECON CORPORATION (US) 1976-04-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240024252-A1 LIPID NANOPARTICLE LIPC, ACOX1, ABCB4 ACE2 2922/4885OPRM1 1547/4885LMNA 1094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.